Vendor, St. Gallen, CHE
Universitat St. Gallen
UEI LLK6D5M1UAF1, CAGE SZA17
2 awards and $515,770 obligated between April 10, 2024 and September 8, 2025, 100% under full and open competition, against 1.0 offers on average where reported. 9 of the awards trace back to a SAM.gov solicitation on this site.
Industries
NAICS on the awards, by dollars.
| Research and Development in Biotechnology (except Nanobiotechnology)NAICS 541714 | $515,770 |
How it wins
Awards by competition, set-aside and type.
| Full and Open Competition | 2 |
| Definitive Contract | 2 |
Awards
Every award in the window, by dollars obligated.
| Contract | Awarding office | Described as | Obligated |
|---|---|---|---|
| 75F40125C00063Definitive Contract, September 8, 2025, Full and Open Competition, 1 offersSolicitation | FDA Office of Acq Grant SVCSFood and Drug Administration | The Purpose of This Contract Is to Conduct Research and Develop Tools to Strengthen Post-Market Surveillance of Fda-Regulated Products. the NAICS 541714, PSC AJ11 | $515,770 |
| 75F40121C00161Definitive Contract, April 10, 2024, Full and Open Competition, 1 offers | FDA Office of Acq Grant SVCSFood and Drug Administration | Following the Publication of the US Food and Drug Administration Safety and Innovation Act (Fdasia) in 2012, and the Subsequent EstablishmenNAICS 541714, PSC AN11 | -$0 |
- Places of performance
- Maryland
- Product and service codes
- AJ11 General Science And Technology R&D Services; General Science And Technology; Basic ResearchAN11 Health R&D Services; Health Care Services; Basic Research
- Transactions
- 2 across 2 awards